Keyphrases
COVID-19
78%
Superinfection
52%
COVID-19 Patients
42%
Antibiotic Use
41%
Urinary Tract Infection
38%
Belgian
36%
Antibiotics
32%
Risk Factors
29%
Antimicrobial Stewardship
29%
Antibiotic Prescription
29%
Respiratory Tract
26%
Defined Daily Dose
26%
Antimicrobial Resistance
22%
National Guidelines
22%
Patients with COVID-19
19%
Antibiotic Identification
19%
Post-COVID-19 Era
19%
Ventilator-associated Pneumonia
19%
Prevalence Factors
19%
Tertiary Care
19%
Local Setting
19%
Antibiotic Resistance
19%
Temocillin
19%
Emergency Department
19%
Antibiotic Prescribing
16%
Virus
14%
Resistance Rate
14%
Fever
14%
Brussels
14%
Antimicrobial Stewardship Team
13%
Diagnosis of Urinary Tract Infection
13%
Hospitalized Patients
13%
Potential Risk Factors
12%
Serology
11%
Empiric Antibiotics
11%
Antibiotic Overuse
11%
Randomized Controlled Trial
11%
Infectious Diseases
11%
Stewards
11%
Hospitalized COVID-19 Patients
10%
Rational Antibiotic Use
10%
Cytokine Release Syndrome
9%
Retrospective Cohort Study
9%
Lung Cancer Patients
9%
European Society
9%
Retrospective Cohort
9%
Gram-negative Bacteria
9%
Ivermectin
9%
Bacteriophage Therapy
9%
Practical Implementation
9%
Medicine and Dentistry
COVID-19
100%
Urinary Tract Infection
36%
Infection
35%
Superinfection
30%
Prevalence
24%
Antibiotic Resistance
22%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Ventilator-Associated Pneumonia
19%
Observational Study
19%
Tertiary Care
19%
Emergency Department
19%
Antimicrobial Stewardship
14%
Temocillin
13%
Virus
13%
Randomized Controlled Trial
11%
Logistic Regression Analysis
11%
Cytokine Release Syndrome
9%
Retrospective Cohort Study
9%
Fulminant
9%
Troponin T
9%
Phage Therapy
9%
Liver Parenchyma
9%
Reverse Transcription Polymerase Chain Reaction
9%
Drug Megadose
9%
Extended Spectrum Beta Lactamase
9%
Diagnostic Accuracy
9%
Corticosteroid
9%
Ciprofloxacin
9%
Renal Tubular Acidosis
9%
Colistimethate
9%
Encephalitis
9%
Interleukin 6
9%
Interleukin 1
9%
Respiratory Tract Infection
9%
Anatomical Barrier
9%
Antimicrobial Therapy
9%
Lung Cancer
9%
Continuous Hemofiltration
9%
Hemodynamic Support
9%
Cohort Analysis
9%
Bacterial Pneumonia
9%
Hepatitis A
9%
Screening Test
9%
Cytokine
9%
Fluid Resuscitation
9%
Cardiac Troponin
9%
Bacteriophage
8%
Antibiotics
7%
Ivermectin
7%
Strongyloides
7%
Pharmacology, Toxicology and Pharmaceutical Science
Superinfection
48%
Urinary Tract Infection
33%
Antibiotic Resistance
33%
Antiinfective Agent
31%
Respiratory Tract
28%
Defined Daily Dose
26%
Prevalence
24%
Infection
24%
Observational Study
19%
Diseases
15%
Temocillin
13%
Coronavirinae
13%
SARS Coronavirus
12%
Randomized Controlled Trial
10%
Antibiotics
9%
Cytokine Release Syndrome
9%
Respiratory Tract Infection
9%
Interleukin 1
9%
Colistimethate
9%
Bacteriophage
9%
Lung Cancer
9%
Extended Spectrum Beta Lactamase
9%
Ciprofloxacin
9%
Beta Lactam Antibiotic
9%
Cytokine
9%
Troponin T
9%
Ventilator Associated Pneumonia
9%
Interleukin 6
9%
Penicillin Derivative
7%
Multidrug-Resistant Gram-Negative Bacteria
6%
Gram Negative Bacterium
6%
Ceftriaxone
6%
Comorbidity
6%
Aminoglycoside
5%
Sulfonamide
5%
Azithromycin
5%
Trimethoprim
5%
Quinolone Derivative
5%
Macrolide
5%